PAVmed Inc. 8-K

What Happened

• On March 30, 2026, PAVmed Inc. (PAVM) announced its financial results for the fiscal year ended December 31, 2025 and provided a business update by issuing a press release.
• The company filed an 8-K (Item 2.02) disclosing those results and made additional Regulation FD disclosure (Item 7.01); the press release is attached as Exhibit 99.1 to the filing.

Key Details

• Date of disclosure: March 30, 2026.
• Reporting period: fiscal year ended December 31, 2025.
• Form 8-K items reported: 2.02 (Results of Operations and Financial Condition) and 7.01 (Regulation FD Disclosure).
• Press release with the results and business update is included as Exhibit 99.1 in the 8-K.

Why It Matters

• This 8-K announces PAVmed’s annual financial results and a business update — material information investors use to assess recent earnings, revenue trends, cash position and company progress.
• Investors should read the attached press release (Exhibit 99.1) for the detailed numbers and management commentary, and monitor subsequent filings (quarterly reports, earnings releases) for further financial detail and guidance.